Pfizer’s Covid vaccination booster is available in Canada for adults

For persons aged 18 and above, Canada approved the use of the booster dose of the Covid vaccine, which was co-developed by Pfizer and BioNTech.
Pfizer/application BioNTech’s for its booster is the first to be approved in Canada, thanks to the decision of the Canadian health authorities.
According to Health Canada, the booster can be given to anyone who have finished the “main series” of two doses at least six months ago.

“Booster dosages are intended to assist people in maintaining their immunity for a longer period of time. After a comprehensive, independent evaluation of the data, Health Canada approved the booster dose, according to a tweet from the agency.

Last month, the National Advisory Committee on Immunization (NACI) recommended that those at risk, including seniors above 70, could be given a booster of a Covid vaccine, while also stating it could be given to those who had two doses of the Astra Zeneca jab.

The announcement from Health Canada came as the country recorded a slight increase in Covid infections. Chief public health officer Dr Theresa Tam tweeted there was a “little bump” in cases with nationally, the seven-day moving average of daily cases was up 4% compared to last week.

“Though not unexpected as more activities move indoors, it’s a reminder we need those layers of protection.” Tam said.

Canada reported 2,380 Covid cases on Tuesday, taking the total to 1737,389. An additional Covid 24 deaths were also reported, taking the overall death toll from the pandemic to 29,217.

Over 84% of those eligible for Covid vaccination (aged 12 and over) have been fully jabbed, making for 74% of the total population.